Effect of a new drug in EAE disease model of multiple sclerosis on the mice gut microbiome
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
Multiple sclerosis is associated with destruction of oligodendrocytes, demyelination and impaired remyelination. Disease modifying therapies available act mainly anti-inflammatory, neuroregenerative substances with potential remyelination-promoting effects are lacking. The impact of a new medicine that closes this gap on the gut microbiome has been studied.
创建时间：
2021-10-08
